Treatment Action Group
By
Treatment Action Group
Published: June 15, 2016, 12:31 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.
Read More →
By
TB CAB,
Treatment Action Group
Published: April 21, 2016, 8:09 p.m.·
Tags:
Global TB response,
Drug-resistant TB,
Advocacy,
TB CAB
Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.
Read More →
By
Treatment Action Group
Published: Jan. 7, 2016, 8:20 p.m.·
Tags:
Global TB response,
Drug-resistant TB,
Advocacy
The targets set forth in the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis are not ambitious enough to effectively stop the spread of multidrug-resistant tuberculosis.
Read More →
By
Erica Lessem,
Treatment Action Group
Published: Dec. 3, 2015, 8:37 p.m.·
Tags:
Access,
Advocacy
Ensuring fair evaluation of and access to tuberculosis treatment.
Read More →
By
Treatment Action Group
Published: Nov. 25, 2015, 1:57 p.m.·
Tags:
Events
2015 Union World Conference on Lung Health
Date: December 4, 2015
Time: 18h00 - 22h30
Location: Southern Sun The Cullinan, 1 Cullinan Street Cape Town Waterfront
Read More →
By
Médecins Sans Frontières,
Treatment Action Group
Published: Nov. 18, 2015, 12:43 p.m.·
Tags:
Events
2015 Union World Conference on Lung Health, Cape Town, South Africa
Date: December 4, 2015
Time: 17h15-18h30
Read More →
By
Treatment Action Group
Published: Oct. 28, 2015, 10:41 p.m.·
Tags:
Global TB response,
Advocacy
"In 1993, the World Health Organization declared TB a global emergency. The new data in the WHO's 2015 Global Tuberculosis Report show that all the promises made to end the TB epidemic since 1993 have been hollow. In 2014, 9.6 million people fell ill with TB, and 1.5 million died of it, making TB the world’s leading infectious killer—surpassing HIV. We have made no progress in reducing the incidence of multidrug-resistant TB (MDR-TB), with nearly half a million people developing MDR-TB in 2014, only one-fourth of them detected, and even fewer started on treatment.
Read More →
By
TB CAB,
Treatment Action Group
Published: July 23, 2015, 5:23 p.m.·
Tags:
Research and development,
Access,
Advocacy,
TB CAB
The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.
Read More →
Page 17 of 23 · Total posts: 10
←First
16
17
18
Last→